Hagop M Kantarjian

306PUBLICATIONS
442CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (306)

|Aug 18, 2026
Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.

|Aug 13, 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

|Jul 24, 2026
Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

|Jul 22, 2026
Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

|Jul 17, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

|Jul 16, 2026
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.

Pageof 51

Frequent Collaborators

171 joint publications

Elias Jabbour

143 joint publications

Tapan M Kadia

124 joint publications

Navel G Daver

120 joint publications

Courtney DiNardo